for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Panacea Biotec gets ANDA approval to market generic version of rizatriptan benzoate tablet

Jan 18 (Reuters) - Panacea Biotec Ltd

* Panacea Biotec Ltd says ANDA approval for us market and lta & award from un agencies for supply of pentavalent vaccine (easyfive-TT)

* Panacea Biotec Ltd says plans to launch product within Q1 2017 via distribution partner in US

* Panacea Biotec Ltd says drug used for treatement of migraine in adults and pediatric patients Source text - (bit.ly/2jISFEc) Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up